Bill Snyder Archive — Page 70 of 121
-
January 8, 2018
Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment
Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia. -
January 4, 2018
Research sheds light on how microtubules are assembled
Microtubules are the “railroad tracks” essential for moving intracellular “freight” around in the cell. They’re also part of the spindle that pulls the two centrosomes apart during cell division. -
December 15, 2017
The toll of dysphagia
Impaired swallowing — dysphagia — affects 3 percent of hospital inpatients, who have longer hospital stays and are more likely to require post-acute care services. -
December 14, 2017
Crowe elected a fellow of the National Academy of Inventors
James Crowe Jr., MD, director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center (VUMC), has been named a fellow of the National Academy of Inventors (NAI). -
December 14, 2017
Matrix biology society honors Hudson’s contributions
Vanderbilt University Medical Center (VUMC) biochemist Billy Hudson, PhD, has been awarded the 2018 Distinguished Investigator Prize by the International Society for Matrix Biology for his contributions to the field of matrix biology. -
December 14, 2017
UCLA’s Lewis set for next Discovery Lecture
Roger Lewis, MD, PhD, a national expert on methods that can improve the flexibility and efficiency of clinical trials, will deliver the next Flexner Discovery Lecture on Thursday, Jan. 4, 2018.